|
Neo-cortefDrug - Neo-cortef The trade name of the product as shown on the labeling.
Dosage -
OINTMENT; TOPICAL
Active Ingredient(s) -
Hydrocortisone Acetate; Neomycin Sulfate
Strength -
0.5%;EQ 3.5MG BASE/GM
Applicant -
PHARMACIA AND UPJOHN
New Drug Application (NDA) Number -
060751
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Pharmacia And Upjohn Co
Neo-cortef
Neo-cortef 0.5%;eq 3.5mg Base/gm Ointment; Ophthalmic
Neo-cortef 1.5%;eq 3.5mg Base/gm Ointment; Ophthalmic Neo-cortef 0.5%;eq 3.5mg Base/gm Ointment; Topical Hydrocortone 1.5% Ointment; Ophthalmic, Otic Cortef Acetate 1% Ointment; Topical Cortef Acetate 2.5% **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Ointment; Topical Orabase Hca 0.5% Paste; Topical Hydrocortisone Acetate 100% Powder; For Rx Compounding Neo-cortef 1%;eq 3.5mg Base/gm Cream; Topical Neo-cortef 2.5%;eq 3.5mg Base/gm Cream; Topical NewDrugInformation |